Applied UV Continues International Expansion with Airocide(R) Hospital Installation in Thailand

News Source: 
Airocide® technology helps hospitals to remain open to protect patients, visitors and staff
 
MOUNT VERNON, NY / ACCESSWIRE / July 21, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ( "UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its Thailand distributor, V Eye Precision Ltd,has installed additional Airocide® units in Bangkok Metropolitan Administration Lat Krabang Hospital, to help create safer and cleaner environments for patients, visitors and staff. Applied UV continues to enhance its distributor relationships throughout Southeast Asia to meet the demand for its air and surface infection control products.
 
Lat Krabang Hospital had previously installed Airocide® systems to control airborne diseases within the hospital environment which is crowded with patients and staff every day. With the resumption of elective procedures and the ongoing fight against COVID-19, the hospital recently installed additional Airocide® units and today have a total of fifteen Airocide® systems protecting critical areas within the facility.
 
Ben Thaiaporn Managing Director, V Eye Precision Ltd, commented, "We are very proud to be Thailand's Airocide dealer for these last 6 years. The installation of the Airocide GCS series units at Lat Krabang Hospital demonstrates the commitment of Thailand's medical community to seek out and provide the best in air purification and sanitizing technology by which to protect their employees and patients."
 
"The hospital environment poses a threat to the health and safety of patients as it is regarded as a source and reservoir of infection. Health-care associated infections ("HAIs") continue to have an outsized negative impact on public health," said Q Saeed, CEO of Applied UV.
 
"Installing Airocide systems in communal spaces, such as in patient and waiting rooms, corridors and break areas to interrupt the transmission of airborne infectious agents and destroy those microbes in a matter of seconds can assist any healthcare institution in its control and elimination of hazardous microorganisms ."
 
Airocide® utilizes NASA optimized photocatalytic oxidation ("PCO") technology wherein air and any contaminants are drawn from the room into the Airocide® unit and channeled into the reaction chamber. UVC activates the proprietary photocatalyst embedded in the reaction chamber, beginning the photocatalytic process . In the reaction chamber, hydroxyl radicals and super-oxide ions are generated and oxidize every organic molecule that comes in contact. The reaction bed is designed to allow the surface-bound radicals nearly three hundred and sixty degrees of exposure for maximum likelihood of collisions with pathogens and other organic material. Millions of hydroxyl radicals converge, combining with the carbon atoms in pathogens (airborne bacteria, mold, fungi, mycotoxins, viruses, allergens) and VOCs,converting the organic material into a harmless vapor and clean, clear air.
 
Airocide® System
 
The Airocide® System, originally developed by NASA with assistance from the University of Wisconsin at Madison, is an airborne pathogen killing technology that uses a patented combination of UVC and a proprietary, titanium dioxide based photocatalyst. Listed as an FDA Class II Medical device, the Airocide® technology is clinically proven and field tested to kill/remove/eliminate airborne pathogenic and non-pathogenic microorganisms, allergens, odors and harmful VOCs in a variety of applications and industries including healthcare, hospitality, grocery chains, wineries, commercial real estate , schools, dental offices and homes. Airocide® air purifiers are available at  www.airocide.com
 
About Applied UV
 
Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries - SteriLumen, Inc. ("SteriLumen") and Munn Works, LLC (" Munn Works"). SteriLumen's connected platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections ("HAIs"). Targeted for use in facilities that have high customer turnover such as hospitals, hotels, commercial facilities, and other public spaces, the Company's Lumicide™ platform uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms,killing bacteria, viruses, and other pathogens residing on hard surfaces within devices' proximity. The Company's patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen intensive location. SteriLumen's Airocide® products for air purification, developed by NASA and FDA Cleared as class II medical devices, utilize a proprietary photo-catalytic bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous pathogens, destructive VOCs and biological gasses into harmless water vapor without producing ozone or other harmful byproducts. Airocide® applications include healthcare, hospitality, grocery chains, wine making facilities, commercial real estate, schools, dental offices, and homes.and other pathogens residing on hard surfaces within devices' proximity. The Company's patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen intensive location. SteriLumen's Airocide® products for air purification, developed by NASA and FDA Cleared as class II medical devices, utilize a proprietary photo-catalytic bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous pathogens, destructive VOCs and biological gasses into harmless water vapor without producing ozone or other harmful byproducts . Airocide® applications include healthcare, hospitality, grocery chains, wine making facilities, commercial real estate, schools, dental offices, and homes.and other pathogens residing on hard surfaces within devices' proximity. The Company's patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen intensive location. SteriLumen's Airocide® products for air purification, developed by NASA and FDA Cleared as class II medical devices, utilize a proprietary photo-catalytic bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous pathogens, destructive VOCs and biological gasses into harmless water vapor without producing ozone or other harmful byproducts . Airocide® applications include healthcare, hospitality, grocery chains, wine making facilities, commercial real estate, schools, dental offices, and homes.
 
For more information about Applied UV, Inc., and its subsidiaries, please visit the following websites:  https://www.applieduvinc.com/https://sterilumen.com/ ; and,  https://munnworks.com/ .
 
 

 

TrendForce 2021 Deep UV LED Application Market and Branding Strategies
Release: 01 May 2021
Language: Traditional Chinese / English
Format: PDF

If you would like to know more details , please contact:

Global Contact:
 
ShenZhen:
Grace Li
E-mail :  Graceli@trendforce.com
Tel : +886-2-8978-6488 ext.916
  Perry Wang
E-mail :  Perrywang@trendforce.cn
Tel : +86-755-82838931 ext.6800
Disclaimers of Warranties
1. The website does not warrant the following:
1.1 The services from the website meets your requirement;
1.2 The accuracy, completeness, or timeliness of the service;
1.3 The accuracy, reliability of conclusions drawn from using the service;
1.4 The accuracy, completeness, or timeliness, or security of any information that you download from the website
2. The services provided by the website is intended for your reference only. The website shall be not be responsible for investment decisions, damages, or other losses resulting from use of the website or the information contained therein<
Proprietary Rights
You may not reproduce, modify, create derivative works from, display, perform, publish, distribute, disseminate, broadcast or circulate to any third party, any materials contained on the services without the express prior written consent of the website or its legal owner.
XLamp® XP-G3 LEDs are optimized for directional, high lumen lighting applications where efficacy and optical control are critical, such as roadway, portable and horticulture. The compact and proven 3.45 mm XP platform has an excellent ecosyst... READ MORE

Nichia further demonstrates its commitment in UV-C LED technology with its release of the high output NC4U334BR. Tokushima, Japan — 6 October 2021: NICHIA, the world’s largest LED manufacturer and inventor of the high-brightness bl... READ MORE